Cognition Therapeutics is currently prioritizing zervimesine for DLB psychosis. This is after the FD

- Zervimesine Would be the First Long-term, Durable Treatment Option with an Impact on Underlying Di

Amid cautious discretionary spending and macro troubles, investments in cutting-edge solutions are l

Arista Networks (NYSE: ANET), a leader in modern AI fabric networking, today announced the Arista [u

Dolby Vision and Dolby Atmos to Power Telemundo's FIFA World Cup 2026™ Coverage on Peacock, a Stre

Dolby Laboratories, Inc. (DLB) Presents at 2026 Baird Global Consumer, Technology & Services Confere

Dolby Laboratories, Inc. (DLB) Presents at 46th Annual William Blair Growth Stock Conference Transcr

As theranostics adoption acceleratesi and radiopharmaceutical demand grows,ii healthcare systems are

/PRNewswire/ -- Dolby Laboratories (NYSE: DLB), a leader in immersive entertainment, and rednote, th

SAN FRANCISCO, May 20, 2026 /PRNewswire/ -- Dolby Laboratories  (NYSE: DLB), a leader in immersive e

SAN FRANCISCO, May 19, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced that

Sony Q4 FY2025 revenues jump 8% to 3,036.4B yen, but GAAP EPS fall to 13.93 yen as gaming and "All O

Dolby Labs is rated a 'BUY' with a conservative $80/share price target, reflecting 17–25% annualized

U.S. stocks hit fresh records as Apple's blowout Q2 powered Big Tech, while crude oil sank 3% on

Dolby stock is getting static over its Q3 earnings guidance.

DLB beats Q2 estimates as licensing growth, strong broadcast demand and expanding Dolby Atmos adopti

Dolby Laboratories, Inc. (DLB) Q2 2026 Earnings Call Transcript

The headline numbers for Dolby Laboratories (DLB) give insight into how the company performed in the

Dolby Laboratories (DLB) came out with quarterly earnings of $1.37 per share, beating the Zacks Cons

Dolby Laboratories (NYSE:DLB) is looking for Q3 Adj EPS of $0.56-$0.71 vs $0.98 analyst estimate. se

Dolby Laboratories (NYSE:DLB) lowers FY2026 GAAP EPS guidance from $2.71-$2.86 to $2.66-$2.81 vs $2.

Dolby Laboratories (NYSE:DLB) affirms FY2026 Adj EPS guidance from $4.30-$4.45 to $4.30-$4.45 vs $4.

Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $1.37 per share which beat the analyst

SAN FRANCISCO, April 30, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB) today announced t

Dolby Laboratories (NYSE: DLB - Get Free Report) has earned a consensus recommendation of "Moderate

Barrington Research analyst Patrick Sholl maintains Dolby Laboratories (NYSE:DLB) with a Outperfo

Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintain

Dolby Laboratories (NYSE:DLB) raises FY2026 GAAP EPS guidance from $2.61-$2.76 to $2.71-$2.86 vs $2.

Dolby Laboratories (NYSE:DLB) raises FY2026 Adj EPS guidance from $4.19-$4.34 to $4.30-$4.45 vs $4.2

Dolby Laboratories (NYSE:DLB) is looking for Q2 Adj EPS of $1.29-$1.44 vs $1.37 analyst estimate. se

Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $1.06 per share which beat the analyst

Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintain

https://aws.amazon.com/blogs/media/from-flat-to-full-immersion-the-aws-path-to-dolby-vision-and-dolb

Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and lowers t

Dolby Laboratories (NYSE:DLB) is looking for FY2026 Adj EPS of $4.19-$4.34 vs $3.96 analyst estimate

Dolby Laboratories (NYSE:DLB) is looking for Q1 Adj EPS of $0.79-$0.94 vs $1.14 analyst estimate. se

Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $0.99 per share which beat the analyst

https://engineering.fb.com/2025/11/17/ios/enhancing-hdr-on-instagram-for-ios-with-dolby-vision/

Barrington Research analyst Patrick Sholl maintains Dolby Laboratories (NYSE:DLB) with a Outperfo